Communicable Disease and Health Protection Quarterly Review: October to December 2003. From the Health Protection Agency, Communicable Disease Surveillance Centre.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002644:Chickenpox / Q000517:prevention & control; D019433:Chickenpox Vaccine / Q000008:administration & dosage; D003140:Communicable Disease Control; D003141:Communicable Diseases / Q000453:epidemiology* / Q000635:transmission; D004196:Disease Outbreaks / Q000517:prevention & control*; D024881:Drug Resistance, Bacterial; D005260:Female; D005759:Gastroenteritis / Q000453:epidemiology / Q000382:microbiology; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007877:Legionnaires' Disease / Q000453:epidemiology; D008288:Malaria / Q000453:epidemiology; D008297:Male; D008585:Meningitis, Meningococcal / Q000453:epidemiology; D008875:Middle Aged; D009031:Moscow / Q000453:epidemiology; D012478:Salmonella Food Poisoning / Q000453:epidemiology; D018571:Sentinel Surveillance; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000382:microbiology; D013742:Tetanus / Q000453:epidemiology; D014195:Travel; D006113:United Kingdom / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D019433:Chickenpox Vaccine